ARCHIVES

Clinical Trials Approved By NCI Last Month Listed

This article is from The Cancer Letter archive.

Vol. 25 No. 2 | February 22, 2002

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

NCI Begins TAILORx Study.

May 26, 2006

Zerhouni forms steering committee; Olden to retire.

August 1, 2003

Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy

August 7, 1981